What is the most recent earnings date for IMPL stock?
IMPEL PHARMACEUTICALS INC (IMPL) last reported earnings on 11/14/2023.
IMPEL PHARMACEUTICALS INC (IMPL) Earnings History & Surprises
NASDAQ:IMPL • US45258K1097
Current stock price
0.2411 USD
-0.17 (-41.79%)
At close:
0.22 USD
-0.02 (-8.75%)
After Hours:
IMPL Earnings overview
Past quarterly earnings results for IMPEL PHARMACEUTICALS INC (IMPL), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- N/A
- Period
- Q4 / 2023
- EPS Estimate
- -$0.21
- Revenue Estimate
- 9.894M
Last Reported
Most Recent- Release Date
- Nov 14, 2023
- Period
- Q3 / 2023
- EPS Reported
- -$0.58
- EPS Surprise
- -57.95%
- Revenue Surprise
- %
Beat Rate
Last 8 Quarters 6%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2023 | -0.58 | -0.37 | -57.95% | 55.73% | 8.16M | - | 164.94% | |
| Q2 2023 | -0.86 | -0.67 | -28.72% | 21.10% | 6.58M | 6.63M | -0.75% | 135.00% |
| Q1 2023 | -1.27 | -0.92 | -38.34% | -8.55% | 4.37M | 5.848M | -25.27% | 148.30% |
| Q4 2022 | -0.97 | -1.14 | 14.63% | 9.35% | 5.01M | 5.065M | -1.09% | 763.79% |
| Q3 2022 | -1.31 | -1.02 | -28.11% | -5.65% | 3.08M | 5.942M | -48.17% | 3,322.22% |
| Q2 2022 | -1.09 | -1.07 | -1.45% | 0.91% | 2.8M | 3.91M | -28.39% | - |
| Q1 2022 | -1.17 | -1.07 | -8.90% | -116.67% | 1.76M | 1.836M | -4.14% | - |
| Q4 2021 | -1.07 | -0.89 | -20.12% | - | 580K | 1.357M | -57.26% | - |
| Q3 2021 | -1.24 | -0.77 | -62.09% | - | 90K | - | - | |
| Q2 2021 | -1.10 | -0.61 | -79.74% | - | - | - | ||
| Q1 2021 | -0.54 | -0.95 | 43.07% | - | - | - | ||
| Q4 2020 | - | - | - | - | ||||
| Q3 2020 | - | - | - | - | ||||
| Q2 2020 | - | - | - | - | ||||
| Q1 2020 | - | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
1
Average EPS beat (4)
-20.14%
Max EPS beat (4)
14.63%
Min EPS beat (4)
-38.34%
Revenue beat statistics
Revenue beat (4)
0
Average Revenue beat (4)
-18.82%
Max Revenue beat (4)
-0.75%
Min Revenue beat (4)
-48.17%
Analysis
In the last 4 quarters, IMPL has beaten EPS estimates in 1 out of 4 releases
IMPL has not beaten revenue estimates in any of the last 4 earnings releases
In the last 4 quarters, IMPL reported -20.1% below the EPS estimates on average.
In the last 4 quarters, IMPL reported -18.8% below the revenue estimates on average.
Related analysis
IMPEL PHARMACEUTICALS INC / IMPL Earnings FAQ
Did IMPL stock beat earnings estimates in the most recent quarter?
IMPEL PHARMACEUTICALS INC (IMPL) missed EPS estimates and missed revenue estimates in the most recent quarter.
How often does IMPEL PHARMACEUTICALS INC (IMPL) beat earnings estimates?
In the last 4 quarters, IMPEL PHARMACEUTICALS INC (IMPL) has beaten EPS estimates in 1 out of 4 releases.